Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Prevention of Post-Dural Puncture Headache in Cesarean Section
NCT06444737Recruiting
- Sponsor
- Mongi Slim University Hospital
- Start
- Nov 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ondansetron in post-dural puncture headache (PDPH) (2 arms), sponsored by Mongi Slim University Hospital. Primary endpoint: Incidence of post-dural puncture headache at 7 days. Started Nov 2023; status: recruiting.
02
Drugs
ondansetron
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT06444737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06444737.